Cargando…

VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA

The HIV-1 envelope (Env) undergoes conformational changes during infection. Broadly neutralizing antibodies (bNAbs) are typically isolated by using soluble Env trimers, which do not capture all Env states. To address these limitations, we devised a vesicular stomatitis virus (VSV)-based probe to dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Manxue, Liberatore, Rachel A., Guo, Yicheng, Chan, Kun-Wei, Pan, Ruimin, Lu, Hong, Waltari, Eric, Mittler, Eva, Chandran, Kartik, Finzi, Andrés, Kaufmann, Daniel E., Seaman, Michael S., Ho, David D., Shapiro, Lawrence, Sheng, Zizhang, Kong, Xiang-Peng, Bieniasz, Paul D., Wu, Xueling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294236/
https://www.ncbi.nlm.nih.gov/pubmed/32315598
http://dx.doi.org/10.1016/j.chom.2020.03.024
_version_ 1783546444274204672
author Jia, Manxue
Liberatore, Rachel A.
Guo, Yicheng
Chan, Kun-Wei
Pan, Ruimin
Lu, Hong
Waltari, Eric
Mittler, Eva
Chandran, Kartik
Finzi, Andrés
Kaufmann, Daniel E.
Seaman, Michael S.
Ho, David D.
Shapiro, Lawrence
Sheng, Zizhang
Kong, Xiang-Peng
Bieniasz, Paul D.
Wu, Xueling
author_facet Jia, Manxue
Liberatore, Rachel A.
Guo, Yicheng
Chan, Kun-Wei
Pan, Ruimin
Lu, Hong
Waltari, Eric
Mittler, Eva
Chandran, Kartik
Finzi, Andrés
Kaufmann, Daniel E.
Seaman, Michael S.
Ho, David D.
Shapiro, Lawrence
Sheng, Zizhang
Kong, Xiang-Peng
Bieniasz, Paul D.
Wu, Xueling
author_sort Jia, Manxue
collection PubMed
description The HIV-1 envelope (Env) undergoes conformational changes during infection. Broadly neutralizing antibodies (bNAbs) are typically isolated by using soluble Env trimers, which do not capture all Env states. To address these limitations, we devised a vesicular stomatitis virus (VSV)-based probe to display membrane-embedded Env trimers and isolated five bNAbs from two chronically infected donors, M4008 and M1214. Donor B cell receptor (BCR) repertoires identified two bNAb lineages, M4008_N1 and M1214_N1, that class-switched to immunoglobulin G (IgG) and IgA. Variants of these bNAbs reconstituted as IgA demonstrated broadly neutralizing activity, and the IgA fraction of M1214 plasma conferred neutralization. M4008_N1 epitope mapping revealed a glycan-independent V3 epitope conferring tier 2 virus neutralization. A 4.86-Å-resolution cryogenic electron microscopy (cryo-EM) structure of M1214_N1 complexed with CH505 SOSIP revealed another elongated epitope, the V2V5 corridor, extending from V2 to V5. Overall, the VSV(ENV) probe identified bNAb lineages with neutralizing IgG and IgA members targeting distinct sites of HIV-1 Env vulnerability.
format Online
Article
Text
id pubmed-7294236
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cell Press
record_format MEDLINE/PubMed
spelling pubmed-72942362020-06-17 VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA Jia, Manxue Liberatore, Rachel A. Guo, Yicheng Chan, Kun-Wei Pan, Ruimin Lu, Hong Waltari, Eric Mittler, Eva Chandran, Kartik Finzi, Andrés Kaufmann, Daniel E. Seaman, Michael S. Ho, David D. Shapiro, Lawrence Sheng, Zizhang Kong, Xiang-Peng Bieniasz, Paul D. Wu, Xueling Cell Host Microbe Article The HIV-1 envelope (Env) undergoes conformational changes during infection. Broadly neutralizing antibodies (bNAbs) are typically isolated by using soluble Env trimers, which do not capture all Env states. To address these limitations, we devised a vesicular stomatitis virus (VSV)-based probe to display membrane-embedded Env trimers and isolated five bNAbs from two chronically infected donors, M4008 and M1214. Donor B cell receptor (BCR) repertoires identified two bNAb lineages, M4008_N1 and M1214_N1, that class-switched to immunoglobulin G (IgG) and IgA. Variants of these bNAbs reconstituted as IgA demonstrated broadly neutralizing activity, and the IgA fraction of M1214 plasma conferred neutralization. M4008_N1 epitope mapping revealed a glycan-independent V3 epitope conferring tier 2 virus neutralization. A 4.86-Å-resolution cryogenic electron microscopy (cryo-EM) structure of M1214_N1 complexed with CH505 SOSIP revealed another elongated epitope, the V2V5 corridor, extending from V2 to V5. Overall, the VSV(ENV) probe identified bNAb lineages with neutralizing IgG and IgA members targeting distinct sites of HIV-1 Env vulnerability. Cell Press 2020-06-10 /pmc/articles/PMC7294236/ /pubmed/32315598 http://dx.doi.org/10.1016/j.chom.2020.03.024 Text en © 2020 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jia, Manxue
Liberatore, Rachel A.
Guo, Yicheng
Chan, Kun-Wei
Pan, Ruimin
Lu, Hong
Waltari, Eric
Mittler, Eva
Chandran, Kartik
Finzi, Andrés
Kaufmann, Daniel E.
Seaman, Michael S.
Ho, David D.
Shapiro, Lawrence
Sheng, Zizhang
Kong, Xiang-Peng
Bieniasz, Paul D.
Wu, Xueling
VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA
title VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA
title_full VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA
title_fullStr VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA
title_full_unstemmed VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA
title_short VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA
title_sort vsv-displayed hiv-1 envelope identifies broadly neutralizing antibodies class-switched to igg and iga
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294236/
https://www.ncbi.nlm.nih.gov/pubmed/32315598
http://dx.doi.org/10.1016/j.chom.2020.03.024
work_keys_str_mv AT jiamanxue vsvdisplayedhiv1envelopeidentifiesbroadlyneutralizingantibodiesclassswitchedtoiggandiga
AT liberatorerachela vsvdisplayedhiv1envelopeidentifiesbroadlyneutralizingantibodiesclassswitchedtoiggandiga
AT guoyicheng vsvdisplayedhiv1envelopeidentifiesbroadlyneutralizingantibodiesclassswitchedtoiggandiga
AT chankunwei vsvdisplayedhiv1envelopeidentifiesbroadlyneutralizingantibodiesclassswitchedtoiggandiga
AT panruimin vsvdisplayedhiv1envelopeidentifiesbroadlyneutralizingantibodiesclassswitchedtoiggandiga
AT luhong vsvdisplayedhiv1envelopeidentifiesbroadlyneutralizingantibodiesclassswitchedtoiggandiga
AT waltarieric vsvdisplayedhiv1envelopeidentifiesbroadlyneutralizingantibodiesclassswitchedtoiggandiga
AT mittlereva vsvdisplayedhiv1envelopeidentifiesbroadlyneutralizingantibodiesclassswitchedtoiggandiga
AT chandrankartik vsvdisplayedhiv1envelopeidentifiesbroadlyneutralizingantibodiesclassswitchedtoiggandiga
AT finziandres vsvdisplayedhiv1envelopeidentifiesbroadlyneutralizingantibodiesclassswitchedtoiggandiga
AT kaufmanndaniele vsvdisplayedhiv1envelopeidentifiesbroadlyneutralizingantibodiesclassswitchedtoiggandiga
AT seamanmichaels vsvdisplayedhiv1envelopeidentifiesbroadlyneutralizingantibodiesclassswitchedtoiggandiga
AT hodavidd vsvdisplayedhiv1envelopeidentifiesbroadlyneutralizingantibodiesclassswitchedtoiggandiga
AT shapirolawrence vsvdisplayedhiv1envelopeidentifiesbroadlyneutralizingantibodiesclassswitchedtoiggandiga
AT shengzizhang vsvdisplayedhiv1envelopeidentifiesbroadlyneutralizingantibodiesclassswitchedtoiggandiga
AT kongxiangpeng vsvdisplayedhiv1envelopeidentifiesbroadlyneutralizingantibodiesclassswitchedtoiggandiga
AT bieniaszpauld vsvdisplayedhiv1envelopeidentifiesbroadlyneutralizingantibodiesclassswitchedtoiggandiga
AT wuxueling vsvdisplayedhiv1envelopeidentifiesbroadlyneutralizingantibodiesclassswitchedtoiggandiga